More information: Takuya Nakagawa et al, Inhibition of human-HPV hybrid ecDNA enhancers reduces oncogene expression and tumor growth in oropharyngeal cancer, Nature Communications (2025). DOI: 10. ...

New clinical insights support U.S. doctors in using transoral robotic surgery (TORS) to personalize treatment plans for ...

A team of Bentonville West High School students is being recognized nationally for developing an app capable of detecting ...

estimates that 59,660 people will receive an oral cavity cancer or oropharyngeal cancer diagnosis in 2025, and 12,770 of these cases will be fatal. Keep reading to learn more about what oral ...

The session titled “Defeating Cancer by Curing Infections” at European Society of Clinical Microbiology and Infectious ...

A sore in the mouth, ongoing hoarseness, a sore throat that won’t go away… All of these symptoms can be associated with a ...

Cancer is a debilitating illness that remains a persistent threat to humanity and is one of the leading causes of death ...

This category includes nasopharyngeal cancer (upper throat), oropharyngeal cancer (middle throat), and hypopharyngeal cancer (bottom portion of the throat). Laryngeal cancer affects the larynx or ...

HPV and human genes can combine to form extrachromosomal circular DNA (ecDNA) in oropharyngeal cancer cells, which enhances tumor-promoting gene expression and accelerates tumor growth.

The number of Americans nationwide with oral or oropharyngeal cancer cases this year is expected to reach 58,500, according to the Oral Cancer Foundation. It will likely cause over 12,250 deaths.

The incidence of Human Papillomavirus (HPV)-associated oropharyngeal cancers — tumors of the back of the mouth and throat — is rising. If caught early, most of these cancers have a high ...